Amlodipine nursing considerations
Pro Research Analysisby 
Searched over 200M research papers
Nursing Considerations for Amlodipine
Overview of Amlodipine Use in Nursing
Amlodipine is a calcium channel blocker commonly used to treat hypertension and angina. It is essential for nurses to understand the specific considerations when administering this medication to ensure patient safety and efficacy.
Amlodipine and Breastfeeding Safety
Low Levels in Breast Milk
Amlodipine has been studied for its safety in breastfeeding mothers. Research indicates that the concentration of amlodipine in breast milk is relatively low, with a milk/plasma ratio averaging 1.4. The relative infant dose (RID) was found to be 3.4% of the maternal weight-adjusted dose, suggesting minimal exposure to the infant. Plasma concentrations in infants were below the quantitation limit, indicating that amlodipine can be used with little influence on infants during breastfeeding 2.
Safety Profile of Amlodipine
General Safety and Side Effects
Amlodipine has a favorable safety profile compared to other antihypertensive agents. In clinical studies, the incidence of severe side effects was lower in patients receiving amlodipine compared to those on beta-blockers like atenolol and nadolol. The most common side effect associated with amlodipine is edema, which is generally well tolerated. Unlike hydrochlorothiazide, amlodipine does not adversely affect serum creatinine, urate, fasting glucose, cholesterol, or triglyceride levels 3.
Considerations for Specific Populations
Amlodipine is well tolerated by elderly patients and does not require dosage adjustments for those with renal impairment. However, the dosage regimen for patients with hepatic impairment is not yet established, necessitating careful monitoring and potential dosage adjustments in these patients 3.
Combined Treatment Approaches
Amlodipine and Traditional Chinese Medicine
A study explored the combined use of amlodipine besylate with acupoint application of traditional Chinese medicine in treating renal failure and hypertension. This combination was found to significantly reduce systolic and diastolic blood pressures and improve renal function markers such as blood urea nitrogen (BUN) and creatinine (CRE). The treatment also showed beneficial effects on renal tissue pathology and molecular markers, suggesting that this combined approach could enhance the therapeutic effects of amlodipine in specific patient populations 1.
Conclusion
Nurses should be aware of the low risk associated with amlodipine use during breastfeeding, its favorable safety profile, and the potential benefits of combining it with traditional Chinese medicine for treating hypertension and renal failure. Proper patient monitoring and individualized care are essential to maximize the therapeutic benefits of amlodipine while minimizing potential risks.
Sources and full results
Most relevant research papers on this topic